Switch Dataset:
We are collecting the most relevant tech news and provide you with a handy archive. Use the search to find mentions of your city, accelerator or favorite startup in the last 1,000 news items. If you’d like to do a more thorough search, please contact us for help.
Search for any keyword to filter the database with >10,000 news articles
id | date | title | slug | Date | link | content | created_at | feed_id |
---|---|---|---|---|---|---|---|---|
42,892 | 16/05/2024 03:12 PM | HEPHAISTOS-Pharma secures €4.3M Seed funding for cancer immunotherapies | hephaistos-pharma-secures-euro43m-seed-funding-for-cancer-immunotherapies | 16/05/2024 | HEPHAISTOS-Pharma, a biotechnology company developing next-generation immunotherapies against cancer that target innate immunity to increase patient cure rates, has completed its €4.3 million Seed round to finance industrialisation and advance its lead candidate, ONCO-Boost, towards the clinic. This brings the funding total to €10.3 million from investors and non-dilutive financing. ONCO-Boost is the first product from HEPHAISTOS-Pharma’s platform. It stimulates the patient’s own immune system, strengthening both innate and adaptive immune systems, to increase their responses against cold tumours. ONCO-Boost can work both as a single agent and in combination with established immunotherapies that do not work against cold tumours, boosting their efficacy to breakthrough levels. Administered intravenously, ONCO-Boost is the first immunostimulant to demonstrate simultaneous efficacy against both primary tumours and metastases. HEPHAISTOS-Pharma is headquartered in France, with a subsidiary in Liège, Belgium. Elaia leads a consortium previously initiated by xista science ventures, the Fondation Fournier-Majoie and Noshaq. Florian DENIS, Investment Director at Elaia, stated:
According to Frederic CAROFF, CEO and co-founder of HEPHAISTOS-Pharma:
This seed round will mainly finance the industrialisation of drug production and regulatory toxicity studies to file for the CTA in Europe. HEPHAISTOS already has a lot of preclinical data in many cancer indications, but they plan to generate new additional data in monotherapy against unmet medical needs and in combination with promising drugs from other pharmaceutical companies. Finally, it will also help to recruit new talents and complete the structuring of the board. Lead image: HEPHAISTOS-Pharma. Photo: uncredited. |
16/05/2024 03:34 PM | 1 | |
42,891 | 16/05/2024 02:55 PM | Airbus’ new Racer is half-plane, half-copter — and it’s lightning-fast | airbus-new-racer-is-half-plane-half-copter-and-its-lightning-fast | 16/05/2024 | Business execs and politicians gathered at a helicopter base in France yesterday for the first public unveiling of Airbus’ new Racer aircraft. At first glance, Racer looks like a regular helicopter. Look closer, however, and you’ll notice it has both wings and two forward-facing rotors. This means it can take-off vertically like a helicopter, and fly fast like a plane — real fast. Racer can reach speeds in excess of 400 km/h. That eclipses civilian helicopters, which cruise at around 200 km/h. It’s even faster than military choppers like the Black Hawk (295 km/h) or Chinook (302 km/h). Racer’s so-called… This story continues at The Next Web |
16/05/2024 03:04 PM | 3 | |
42,889 | 16/05/2024 02:02 PM | Senior executive stands down from roles at card consolidator Curve | senior-executive-stands-down-from-roles-at-card-consolidator-curve | 16/05/2024 | The finance chief at Curve, the card consolidator fintech which has raised more than £200m in equity, is leaving the role. Paul Harrald, who joined Cruve in 2019, is standing down from his role as Curve CFO and CEO of Curve’s lending business. Before joining Curve, Harrald worked at CreditEast, a Chinese VC firm, where he ran UK and European private equity investments. Harrald stood down as a director at Curve on May 13, according to Companies House. Harrald is staying on as an advisor at Curve, which was founded in 2015, and whose backers include IDC Ventures and Santander Ventures, the venture arm of banking giant Santander. The London-based fintech consolidates all of a user's credit and debit cards into a single card and app, to make managing their financial life easier. To date, it has raised over £200 million in equity and has a presence in 32 markets including the UK, several other European markets, and the US. It says it has more than 4.3 million users. Curve’s leading business is called Curve Credit and offers users credit on purchases made via the Curve card, to be paid back in instalments, like Klarna. Its latest account shows revenues were up £7.6 million to £22.1 million in the year ending December 2022, but pre-tax losses widened from £59.1 million to £69.1 million. Curve said it is on the hunt for a new CFO. |
16/05/2024 02:04 PM | 1 | |
42,890 | 16/05/2024 01:58 PM | The rise of the ‘augmented’ startup founder | the-rise-of-the-augmented-startup-founder | 16/05/2024 | The modern startup founder will tell you work never stops. What they’re far less likely to tell you is that stress, anxiety, panic, and feelings of failure never stop either. From worrying about funding and filling skills gaps in an uber-competitive environment, to simply running out of available working time to clear to-do lists — leaders contend with countless unique and interchangeable stresses on a daily basis. Whether it’s a lack of time, money or talent, these stresses contribute to a culture of overworking, and a vicious cycle of inefficiency that affects productivity overall. In the past we’ve seen ‘toxic… This story continues at The Next Web |
16/05/2024 02:04 PM | 3 | |
42,888 | 16/05/2024 01:21 PM | 'Mobilising private capital to address the world's greatest (climate) challenges': Carbon Equity CEO Jacqueline van den Ende is on a mission | mobilising-private-capital-to-address-the-worlds-greatest-climate-challenges-carbon-equity-ceo-jacqueline-van-den-ende-is-on-a-mission | 16/05/2024 |
What made Jacqueline van den Ende decide to start climate fund investment platform Carbon Equity as a way to try and solve some of the world's greatest challenges - with private capital as the main driver? It's the central theme of an enjoyable and insightful conversation we had with the Amsterdam-based company's affable co-founder and CEO, whose career spans entrepreneurship and PE/VC investment. Born in early 2021, today Carbon Equity has more than €200 million in assets under management, has invested in more than 600 investment funds, and backed 100+ climate tech companies directly. That's real impact, and the company is only getting started. But what was the reasoning behind its founding (spoiler alert: a big part of it was a personal wake-up call thanks to a specific book), what is the team trying to accomplish, how unique are they in terms of positioning, and how far along on their journey are they now? You can check out the interview above, on the EIC Scaling Club website, or on YouTube. For more interviews with deep tech scale-up founders, investors and other stakeholders, check out the EIC Scaling Club news section and/or subscribe to its monthly newsletter. (Tech.eu / Webrazzi is a partner in the EIC Scaling Club programme, which aims to connect high-growth European deep tech companies with investors, corporate innovators and many more to level up the ecosystem). |
16/05/2024 01:34 PM | 1 | |
42,885 | 16/05/2024 01:00 PM | Rollercoaster for UK AI scene as PolyAI bags $50M while Stability AI mulls sale | rollercoaster-for-uk-ai-scene-as-polyai-bags-dollar50m-while-stability-ai-mulls-sale | 16/05/2024 | The artificial intelligence scene in Great Britain feels a little bit like your weekly tv drama at the moment. Major funding rounds compete for attention with controversial CEO departures and outlandish government campaigns (“Unicorn Kingdom” and 3D statue holograms, anyone?). London-based PolyAI today announced it had secured a valuation of $500mn following a successful fund raise for its call centre voice assistant tech. It might not be the sexiest of AI applications, but then again not all business bets need to be. While PolyAI is still only halfway towards that coveted unicorn mark of a $1bn valuation, the $50mn raise from… This story continues at The Next Web |
16/05/2024 01:04 PM | 3 | |
42,884 | 16/05/2024 01:00 PM | Leya raises $10.5M for its AI lawyer assistant | leya-raises-dollar105m-for-its-ai-lawyer-assistant | 16/05/2024 | Stockholm legaltech company Leya announced it has raised $10.5 million in a funding round led by Benchmark with participation from Hummingbird, SV Angel, and Y-Combinator. Leya is an AI assistant tailored to lawyers and law firms across all practice areas and workflows. it works with multiple sources of information in conversation, due diligence processes, and drafting to deliver trustworthy responses. This allows lawyers across practice areas, and in-house teams, to confidently apply generative AI in their daily tasks. The company sees AI not as a mere add-on to lawyers' workflow, but as a partner that will work on their behalf in a trustworthy way. It shared:
More concretely, Leya directly accesses files and documents right where they are. It then combines them with legal data from over 15 jurisdictions, always providing sentence-level citations and references to the underlying material in its output; both in Due Diligence reviews, conversations, and when editing or reviewing documents directly. The funds will help scale the team, deepen partnerships and build the future of legal work. Lead image: Leya. Photo: uncredited. |
16/05/2024 01:04 PM | 1 | |
42,886 | 16/05/2024 12:36 PM | Lab-Grown Meat Is on Shelves Now. But There’s a Catch | lab-grown-meat-is-on-shelves-now-but-theres-a-catch | 16/05/2024 | A store in Singapore is selling lab-grown chicken, but it only contains 3 percent animal cells. | 16/05/2024 01:04 PM | 4 | |
42,887 | 16/05/2024 12:19 PM | Growth debt: A strategic financing option for startups | growth-debt-a-strategic-financing-option-for-startups | 16/05/2024 | Growth debt is a form of business financing that involves borrowing funds from specialised lenders, typically dedicated growth debt firms. This type of debt is specifically tailored for startups and high-growth companies, offering an alternative to both traditional bank loans and equity financing. Unlike traditional debt, growth debt is designed around the specific needs of… This content is for members only. Visit the site and log in/register to read.
The post Growth debt: A strategic financing option for startups appeared first on EU-Startups. |
16/05/2024 01:04 PM | 6 | |
42,883 | 16/05/2024 11:09 AM | Meta Faces Fresh Probe Over 'Addictive' Effect on Kids | meta-faces-fresh-probe-over-addictive-effect-on-kids | 16/05/2024 | The EU has launched an investigation into Facebook and Instagram's child protection measures are part of mounting concerns around minors’ use of social media. | 16/05/2024 11:34 AM | 4 | |
42,881 | 16/05/2024 10:03 AM | Artisan AI raises $7.3M to develop autonomous AI employees | artisan-ai-raises-dollar73m-to-develop-autonomous-ai-employees | 16/05/2024 | UK-founded Artisan AI, a startup building AI employees and software for enterprise companies, has raised $7.3 million in funding. The YC-backed company is founded by 22-year-old Jaspar Carmichael-Jack (CEO), Oxford PhD Graduate Dr Rupert Dodkins (CTO), and IBM product and engineering veteran Samantha Stallings (CPO). The company is now based in San Francisco and is building Artisans, fully autonomous AI employees, and a unified platform to replace the entire SaaS stack so that humans and AI can work together seamlessly and enterprise teams can stop context switching. Artisan’s mission is to create an all-in-one platform to replace and consolidate top SaaS products in the go-to market space, where Artisans work alongside human teams to automate the majority of their work. Artisan launched their AI BDR (Business development representative), Ava, in February 2023. Ava currently automates 80 per cent of a Business Development Representative’s (BDR) role, for example, replacing 10s of outbound sales tools into a single, consolidated platform. From Ava to Liam, the Marketing Artisan, and James, the Customer Success ArtisanNext in their pipeline is Liam, the Marketing Artisan, and James, the Customer Success Artisan. CEO Jaspar Carmichael-Jack says:
6 months ago, Artisan was accepted into Y Combinator with a team of 3. Since then, they have launched V2 of their platform, onboarded 100+ companies, and have 13 employees working on their product. AI employees that can perform better than humans — eventuallyArtisan launched V2 of their platform at the beginning of April. This release introduced Level 2 Autonomy of AI Agents, a significant improvement on Level 1, which came out in February 2023. Where Level 1 Ava required manual human review, Level 2 Ava operates on autopilot, independently crafting and sending emails in a variety of styles, without direct human input. These ‘levels’ are based on the levels of AI agent autonomy. At the basic end of the spectrum, where most AI solutions today exist, Level 1 autonomy is where the agent acts upon specific instructions without deviation. Level 2, where Ava currently operates, introduces assisted autonomy, where the system can make certain decisions and perform tasks with minimal human oversight. Artisan is currently working on Level 3 autonomy, where AI agents will not only execute tasks but also begin to manage complex decision-making processes within specified scenarios. The The Artisan team will continue to ascend the levels of autonomy until they achieve Level 5 Artisans – AI employees that can perform better than humans in all hard and soft skills associated with a given role. Lead image: Artisan founders. Photo: uncredited. |
16/05/2024 10:34 AM | 1 | |
42,882 | 16/05/2024 10:00 AM | Maven Is a New Social Network That Eliminates Followers—and Hopefully Stress | maven-is-a-new-social-network-that-eliminates-followersand-hopefully-stress | 16/05/2024 | Twitter cofounder Ev Williams is backing a new social network called Maven, which trades likes and follows for algorithms designed to foster serendipity and deep discussion. | 16/05/2024 10:34 AM | 4 | |
42,878 | 16/05/2024 09:25 AM | A new browser war is brewing in Europe | a-new-browser-war-is-brewing-in-europe | 16/05/2024 | Have you ever been trapped in a bad relationship? I’m stuck in one right now with Google Chrome. The browser’s good looks can no longer hide the ugliness that lurks inside. Chrome devours my laptop’s memory, sucks away its battery, and harvests my data. All the while, the software expands Google’s repressive empire. Chrome, you treat me terribly. Why can’t I quit you? One reason for my undeserved loyalty is that rival browsers have rarely caught my eye. But that’s started to change. A raft of pro-competition rules are pushing alternatives towards the mainstream. Leading the charge is the EU’s… This story continues at The Next Web |
16/05/2024 09:34 AM | 3 | |
42,879 | 16/05/2024 09:20 AM | EU-Startups Podcast | Episode 68: Alex Berriche Co-founder & CEO of Fleet and Sequoia Capital Scout | eu-startups-podcast-or-episode-68-alex-berriche-co-founder-and-ceo-of-fleet-and-sequoia-capital-scout | 16/05/2024 | In this episode, Alex Berriche, Sequoia Capital Scout and the Co-founder and CEO of Fleet, a French B2B startup focused on simplifying equipment management for startups and SMBs, shares lessons learned from over 100 angel investments. He also discusses the idea behind Fleet and the challenges of IT equipment management. Alex shares his transition from… This content is for members only. Visit the site and log in/register to read.
The post EU-Startups Podcast | Episode 68: Alex Berriche Co-founder & CEO of Fleet and Sequoia Capital Scout appeared first on EU-Startups. |
16/05/2024 10:04 AM | 6 | |
42,880 | 16/05/2024 09:01 AM | Berlin-based Caeli Wind snaps €11 million Series A to expand its digital platform for wind energy sites | berlin-based-caeli-wind-snaps-euro11-million-series-a-to-expand-its-digital-platform-for-wind-energy-sites | 16/05/2024 | Caeli Wind, a platform for analysing and marketing wind energy locations founded by Ben Schlemmermeier and Heiko Bartels in 2022, announced that it has secured €11 million in growth capital from international investors. The round was led by renowned UK venture capital fund Notion Capital with the participation of Santander Alternative Investments and existing investors… This content is for members only. Visit the site and log in/register to read.
The post Berlin-based Caeli Wind snaps €11 million Series A to expand its digital platform for wind energy sites appeared first on EU-Startups. |
16/05/2024 10:04 AM | 6 | |
42,876 | 16/05/2024 08:46 AM | French biotech HEPHAISTOS-Pharma gets €4.5 million to develop next-gen of immunostimulants against cancer | french-biotech-hephaistos-pharma-gets-euro45-million-to-develop-next-gen-of-immunostimulants-against-cancer | 16/05/2024 | HEPHAISTOS-Pharma, a biotechnology company developing next generation immunotherapies against cancer targeting innate immunity to increase the cure rate of patients, has completed its €4.5 million seed round to finance industrialization and advance its lead candidate ONCO-Boost towards the clinic. Elaia leads a consortium previously initiated by xista science ventures, the Fondation Fournier-Majoie and Noshaq. Florian… This content is for members only. Visit the site and log in/register to read.
The post French biotech HEPHAISTOS-Pharma gets €4.5 million to develop next-gen of immunostimulants against cancer appeared first on EU-Startups. |
16/05/2024 09:04 AM | 6 | |
42,877 | 16/05/2024 08:17 AM | Tallinn-based medtech Nanordica Medical raises €1.75 million to treat severe wounds with nanotechnology | tallinn-based-medtech-nanordica-medical-raises-euro175-million-to-treat-severe-wounds-with-nanotechnology | 16/05/2024 | Estonian medtech company Nanordica Medical has raised €1.75 million to enter the market with first-in-class wound care products curing severe wounds. The round was led by Estonian fund Specialist VC, with participation from Superangel and Amalfi. 100 million patients suffer from chronic wounds such as diabetic foot, venous leg and pressure ulcers. Moreover, the prevalence… This content is for members only. Visit the site and log in/register to read.
The post Tallinn-based medtech Nanordica Medical raises €1.75 million to treat severe wounds with nanotechnology appeared first on EU-Startups. |
16/05/2024 09:04 AM | 6 | |
42,875 | 16/05/2024 08:02 AM | CUTISS skintech offers life changing hope for burn victims | cutiss-skintech-offers-life-changing-hope-for-burn-victims | 16/05/2024 | Today, I'm writing about a piece of tech that hits close to home. Back in Australia, when my mother was a child, she was severely burned in a kitchen accident from the knee down, resulting in not only severe pain but a lifetime of operations, dealing with severe ulcers, and wearing pressure garments. Swiss biotech company CUTISS is changing the lives of burn victims and those patients requiring reconstructive skin surgery. The company has developed denovoSkin, a personalised, bioengineered skin graft. Classified as an advanced therapy medicinal product, it can be bioengineered in large quantities, starting from a small, stamp-sized piece of the patient's healthy skin. denovoSkin™ is composed of an epidermis (the top protective layer = life) and a dermis (the structural layer below = quality of life) for permanently treating skin defects and injuries. The biopsy is processed to isolate epidermal and dermal cells. The cells are expanded in vitro (and can be bio-banked for further use) and thereafter used in combination with a hydrogel to form tissue. I spoke to Dr Daniela Marino, CEO and co-founder, to learn more. The need for something betterTraditional skin grafts involve taking healthy skin from one area of the body (donor site) and transplanting it to cover a wound or area of damaged/missing skin (recipient site). This can result in scarring, discolouration, or uneven skin surface at the graft or donor site, as well as a loss of flexibility and tightness as the recipient grows, resulting in reduced mobility and the need for new surgeries. Marino is a biotechnologist from Italy who originally came to Switzerland for her PhD and wanted to go to the US or Japan. Postdoc work in skin grafts at the Tissue Biology Research Unit, Department of Surgery, University Children's Hospital Zurich, including first-of-its-kind research in skin grafts. She recalled:
Marino explained:
The benefits of denovoSkinSignificantly, once applied, the skin minimally scars and grows with the patient, drastically reducing the number of follow-up corrective surgeries required, particularly in children. The outcome is potentially life-saving and life-changing. Marino describes the growing skin as very expandable and elastic:
The skin can also be used in reconstructive skin surgery, for example, scar revisions, giant nevi or tumour resections, plastic surgery, and tattoo removal. As a company, CUTISS's main priority is producing high-quality skin tissue. Marino stressed:
However, the company has reduced skin development time from 7 to 8 weeks when this project first started at university, to 3 to 4 today. Simultaneously, CUTISS is working to scale up the production of denovoSkin™ through automation. The company has developed its own unique approach to bioengineering human skin tissue, composed of three automated modules: cell isolation, cell expansion, and skin tissue formation. The denovoCast™ is the world's first machine to bioengineer large, personalised skin tissue grafts in a fully closed loop.
The machine has undergone R&D testing at CUTISS, and the company is ready to start industrialisation. In May 2023, it was awarded a CHF 2.5 million grant to advance the pioneering automation program and support the industrialisation of the denovoCast™ (the tissue formation device). According to Marino:
Skintech in spaceLast year saw a SpacePharma micro-lab, containing an experiment by Cutiss, travel to the ISS on SpaceX's 27th commercial resupply mission (CRS-27) for NASA to observe space travel's effects on skin cells and tissue culture. While data analysis is ongoing, Marino explained:
Earlier scientific attempts have produced much, so the company thought that surfing the wave of space research could open up new opportunities in molecular biology for skin.
The challenge of funding emerging techLike any startup, CUTISS is no stranger to funding challenges. The company is a long-term investment. As Marino noted:
As such, Marino admits that CUTISS has no VC on board yet, maybe because "sometimes they simply don't know how to investigate our technology. So, they have been financed by family offices and foundations and banks which have individuals inside who have either done business in cell therapy or have done studies in cell therapies or simply because they believe it's going to be the future. By comparison, VCs are more structured. The first question is always, 'Are you a biotech or a medtech company?' And I'm like, ' We're a bit of both. We're developing machines to develop skin for therapy.' The company is sometimes asked about potentially more lucrative areas of skin therapy, such as longevity and tattoo removal.
We are at the right time in history with a product that will try to change the status quo in skin surgery. I mean, look at the geopolitical situation, global warming, and the increase of burns due to hot surfaces and, explosions and wildfires. And on top of that, wars generate a population needing significant care." Cutiss is currently submitting for phase three trials, which is the last clinical trial, which hopefully will give the company the authorisation for the product's commercial launch. Lead image: CUTISS denovoSkin. Photo: CSEM.
|
16/05/2024 08:34 AM | 1 | |
42,872 | 16/05/2024 08:00 AM | Carbon13 invests in 6 climatetech startups through its venture launchpad | carbon13-invests-in-6-climatetech-startups-through-its-venture-launchpad | 16/05/2024 | Carbon13, the Venture Builder for the climate emergency Home, is today announcing new investments in six ventures through its accelerator, the Venture Launchpad. Each venture has received £120,000 Pre-Seed investment. The Venture Launchpad is in partnership with Barclays Eagle Labs. The first Launchpad cohort began 12 months ago, and Carbon13 has now invested in 14 ventures in 12 months through the programme. Notable alumni include Natural Building Systems, Pattern Project, Hubl, and Optimise AI. The six ventures, which include cutting-edge technology for biochar-based polystyrene alternatives, smart wall HVAC systems, net-negative insect proteins, AI-powered circular fashion, and food waste management, are united by the cross-cutting theme of waste. Waste represents an opportunity for the six ventures receiving investment from Carbon13’s latest programme. Abatement is only part of their impact: By tackling complex systems to reduce waste, create value, and refine efficiency, these ventures showcase how climate tech can have a legacy beyond emissions. The six ventures receiving investment from the Carbon13:
Five of these Carbon13-backed ventures have female founders (as do over 60 per cent of the whole Carbon13 portfolio) Commenting on the investments, their impact potential, and the profiles of the six ventures, CEO and co-founder of Carbon13, Dr Nicky Dee, said:
Lead image: Jonathan Cumming, Chris Coleridge, Nicky Dee, and Michael Langguth, founders of Carbon13. Photo: uncredited. |
16/05/2024 08:04 AM | 1 | |
42,871 | 16/05/2024 08:00 AM | Nanordica Medical raises €1.75M for advanced antibacterial wound dressing | nanordica-medical-raises-euro175m-for-advanced-antibacterial-wound-dressing | 16/05/2024 | Estonian medtech company Nanordica Medical has raised €1.75 million to enter the market with first-in-class wound care products curing severe wounds. Nanordica Medical, founded in 2019, is a spin-off of the National Institute of Chemical Physics and Biophysics (Estonia). It has developed an advanced antibacterial wound dressing, stemming from the scientific discovery of the co-founders revealing that the combination of copper with silver nanoparticles significantly enhances the antibacterial efficacy of both components and improves wound healing. 100 million patients suffer from chronic wounds such as diabetic foot, venous leg and pressure ulcers. Moreover, the prevalence is increasing by 12 per cent annually due to the aging of the population and the increase in underlying diseases like diabetes and obesity. 1 million amputations worldwide are caused annually by these wounds, and most of them are related to poorly managed bacterial infection of wounds. Patients with infected wounds are typically treated with systemic antibiotics or traditional antibacterials such as silver ion-based dressings or ointments. The Nanordica Medical’s wound dressing inactivated bacterial infection up to 8x better compared to traditional antibacterial solutions. Remarkably, the effect is achieved at very low concentrations, which is important because in this case antibacterial does not harm the patient’s skin cells. A randomised controlled trial of developed wound dressing carried out on 30 patients with infected diabetic foot ulcers showed improved safety and twice as fast healing as one of the most widely used competing silver ion-based wound dressing. According to co-founder and CEO of Nanordica Medical Olesja Bondarenko:
Nanordica Medical’s team is planning a multicentered study involving 170 patients with diabetic foot ulcers in Q2 2024. This will be one of the largest studies of its kind, paving the path to the inclusion of Nanordica Medical’s wound care products into the reimbursement and treatment guidelines. The round was led by Estonian fund Specialist VC, with participation from Superangel and Amalfi. According to Gerri Kodres, the Founder Partner of Specialist VC: “We were inspired by the extraordinary determination and resilience of Nanordica Medical’s founder team. The company’s innovative wound care solution has the potential to positively impact the lives of chronic wound patients across the world.” Nanordica Medical’s first product for veterinary use Ravimus Vet was launched in 2023, and the human product is planned to launch in 2025. Lead image: Nanordica Medical. Photo: uncredited. |
16/05/2024 08:04 AM | 1 | |
42,873 | 16/05/2024 07:23 AM | London-based Native Teams raises €6.2 million to advance remuneration for the new world of work | london-based-native-teams-raises-euro62-million-to-advance-remuneration-for-the-new-world-of-work | 16/05/2024 | Native Teams, a work payments platform for freelancers, remote workers, and business owners, has successfully raised a further round of investment totalling €6.275 million to power its ambitious plans of becoming the go-to platform for work payments. The startup received support from existing investors Eleven Ventures and Fil Rouge Capital and new investors MFG Invest,… This content is for members only. Visit the site and log in/register to read.
The post London-based Native Teams raises €6.2 million to advance remuneration for the new world of work appeared first on EU-Startups. |
16/05/2024 08:04 AM | 6 | |
42,870 | 16/05/2024 07:00 AM | Harbor Lab raises $16M for efficient maritime communication | harbor-lab-raises-dollar16m-for-efficient-maritime-communication | 16/05/2024 | Maritime Software Company Harbor Lab has raised a $16M Series A funding round, led by European VC Atomico, to streamline ports of call at sea. With participation from existing investors Notion Capital, Venture Friends, SpeedInvest and The Dock, and new investors Endeavor Catalyst and maritime VC TMV, the round follows a Seed round of €6.1M. Shipping companies use manual methods to track, analyse and validate port expenses, resulting in a complex web of costs that arise from every port call. Harbor Lab’s platform optimizes and streamlines the port cost management process for shipping companies, enabling a single individual to oversee disbursements for up to 50 vessels vs today’s ratio of 1 to 6 vessels. New environmental legislation and mounting geopolitical crises are further adding to the complications, dangers, and unpredictability in costs of transporting cargo. By streamlining how shipping companies handle these port-related costs, Harbor Lab increases the ratio of vessels reached from a previous 1 to 6 vessels. The platform also mitigates invoicing errors and overpayments by cross-referencing port call expenses with real-time official port tariffs from global port authorities and offers verification for local agents. "By demystifying disbursement accounting, we're not just streamlining operations; we're fostering a culture of trust and innovation across the maritime ecosystem", said Harbor Lab founder Antonis Malaxianakis. Atomico partner Ben Blume added, “Harbor Lab’s platform gives peace of mind to shipping companies by enabling them to run critical parts of their operations in a more seamless, transparent and efficient way. It is already helping businesses around the world - including shipping giants Great Eastern Shipping |
16/05/2024 07:04 AM | 1 | |
42,869 | 16/05/2024 07:00 AM | 10 Norwegian startups to watch in 2024 | 10-norwegian-startups-to-watch-in-2024 | 16/05/2024 | The Norwegian tech ecosystem has experienced significant growth and development in recent years, fueled by a combination of factors including government support, access to capital, a highly educated workforce, and a culture of innovation. Supported by those different initiatives, as the ecosystem matures, Norwegian startups are increasingly making an impact both on the local economy and the global stage. Today we bring you the list of 10 Norwegian startups you should have on your radar in 2024.
|
16/05/2024 07:04 AM | 1 | |
42,874 | 16/05/2024 06:19 AM | London-based Peachies raises €1.6 million to redefine the nappy experience | london-based-peachies-raises-euro16-million-to-redefine-the-nappy-experience | 16/05/2024 | Peachies, a London-based premium nappy brand for contemporary parenting, has announced the successful completion of its latest fundraising round, securing total funding of €1.6. The round included prominent investors from the UK, US, Germany and Austria. It was led by Anotherway Ventures, the fund supporting purpose-led consumer brands and Antler, the most active private early-stage… This content is for members only. Visit the site and log in/register to read.
The post London-based Peachies raises €1.6 million to redefine the nappy experience appeared first on EU-Startups. |
16/05/2024 08:04 AM | 6 | |
42,868 | 16/05/2024 04:00 AM | Roundtable launches micro fund-as-a-service platform for easy VC fund creation | roundtable-launches-micro-fund-as-a-service-platform-for-easy-vc-fund-creation | 16/05/2024 | European investor Roundtable today launches its micro fund-as-a-service product, aiming to enable any investor to quickly and easily launch their own VC fund. Roundtable is a registered EuVECA Manager in Luxembourg. It offers a platform for founders to raise capital via business angels and communities of investors. Investors can also create their own communities and invite others to join and share deals. It previously simplified community investing in startups by facilitating over €250 million in fundraising through 450 deals in the past 12 months. Now it helps investors establish micro funds. Launch a micro fund in hoursRoundtable's new product significantly simplifies and accelerates the process of launching a fund. It sets a much lower minimum of just a few million, as opposed to the usual €50 -100 million minimum required to launch a fund. Second, its standardised all-included fund-as-service-product eliminates the need for navigating complex legislation, dealing with lawyers, and onboarding Limited Partners (LPs). Investors can establish a fund within a few hours instead of months. Roundtable also takes care of all required tasks, such as fund administration, audit, and reporting, enabling the reduction of yearly costs and thus the targeting of fund size. Micro fund investment deals are on the riseIn 2021, micro funds accounted for about 20 per cent of all seed investments in the US, with the number of micro VC fund deals increasing by 219 per cent over the past decade up to 2020. Individuals who are interested in creating a fund are usually influential business Angels, but also Partners or Principals of VC funds who want to launch their own fund, or even Alumni networks such as business schools. Roundtable is currently supporting several micro funds targeting first closings between €10 million and €100 million. Among them is Intuition.vc, a €15 million early-stage fund led by Etienne Boutan and Hugo Amsellem, with investors including footballer Raphaël Varane. Intuition.vc focuses on investing in consumer and culture startups. According to Evan Testa, CEO and co-founder of Roundtable:
Roundtable’s future plans include international expansion and diversifying investment options into real estate and private equity. |
16/05/2024 04:04 AM | 1 |